This is a firm-fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to the foreign-owned, for-profit company Mestrelab Research SL. The award, valued at $168,213.65, is for the renewal of the Mnova NMR/LC/MS software license, a proprietary software currently in use at the agency. The software is integral to the identification, validation, and purity analysis of various chemical compounds and is used daily by the agency's chemists. The contract has a performance period of August 21, 2023 through August 20, 2027, with four 1-year option periods. No set-aside designation was used for this award. Mestrelab Research SL is a subsidiary of the Bruker Corporation.
Generated 4/11/24, 9:53 AM